MIRCERA Side Effects

6960831-0 | Dyspnoea
on Aug 23, 2010 Male patient from UNITED KINGDOM , 24 years of age, weighting 136.7 lb, was diagnosed with anaemia and was treated with Mircera (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea. Mircera dosage: .

6958517-1 | Malaise
Patient was taking Mircera (View Usage). Patient had the following side effects: malaise on Aug 20, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 45 years of age, weighting 251.3 lb, was diagnosed with anaemia and. Mircera dosage: .

6945430-9 | Anaemia, Asthenia, Decreased Appetite, Haemolysis
Adverse event was reported on Aug 15, 2010 by a Female patient taking Mircera (View Usage) (Dosage: ) . Location: UNITED ARAB EMIRATES , 60 years of age, After Mircera was administered, patient had the following side effects: anaemia, asthenia, decreased appetite, haemolysis.

6921086-6 | Haemoglobin Decreased, Serum Ferritin Increased, Sudden Visual Loss
on Aug 05, 2010 Female patient from TURKEY , 58 years of age, weighting 112.4 lb, was treated with Mircera (View Usage). Patient experienced the following unwanted or unexpected effects: haemoglobin decreased, serum ferritin increased, sudden visual loss. Mircera dosage: Route: S.c.. During the same period patient was treated with SEVELAMER (View Sevelamer Review and Sevelamer Label ), AMINO ACID INJ (View Amino Acid Inj Review and Amino Acid Inj Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), VASTAREL (View Vastarel Review and Vastarel Label ).


6908241-6 | Anaemia, Blood Sodium Increased, Hypertensive Encephalopathy, Lung Infection
on Aug 02, 2010 Male patient from FRANCE , weighting 110.2 lb, was diagnosed with prophylaxis, infection prophylaxis and was treated with Mircera (View Usage). Patient had the following side effects: anaemia, blood sodium increased, hypertensive encephalopathy, lung infection. Mircera dosage: Frequency: Monthly. During the same period patient was treated with MABTHERA (View Mabthera Review and Mabthera Label ), BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized.

6832107-3 | Fall, Hypersensitivity, Hypotension
Patient was taking Mircera (View Usage). After Mircera was administered, patient had the following side effects: fall (What is fall?), hypersensitivity, hypotension on Jul 09, 2010 from MALAYSIA Additional patient health information: Male patient , weighting 164.9 lb, was diagnosed with anaemia, hypertension and. Mircera dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CACO3 (View Caco3 Review and Caco3 Label ), FERROUS FUMARATE (View Ferrous Fumarate Review and Ferrous Fumarate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ONE ALPHA (View One-alpha Review and One-alpha Label ).

6828166-4 | Aplasia Pure Red Cell, Encephalitis
Adverse event was reported on Jun 30, 2010 by a Male patient taking Mircera (View Usage) (Dosage: ) . Location: FRANCE , weighting 145.5 lb, Patient experienced the following unwanted or unexpected effects: aplasia pure red cell, encephalitis (What is encephalitis?). During the same period patient was treated with NEORECORMON (Indication: Anemia Due To Chronic Renal Insufficiency) (View Neorecormon Review and Neorecormon Label ), EPREX (Indication: Anemia Due To Chronic Renal Insufficiency) (View Eprex Review and Eprex Label ), ZOVIRAX (View Zovirax Review and Zovirax Label ), DEPAKENE (View Depakene Review and Depakene Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), MONICOR L.P. (View Monicor L.p. Review and Monicor L.p. Label ), LASIX (View Lasix Review and Lasix Label ), DIFFU K (View Diffu K Review and Diffu K Label ).

6826907-3 | Haemoglobin Decreased, Parkinson's Disease
on Jun 21, 2010 Male patient from GERMANY , 45 years of age, was diagnosed with glomerulonephritis and was treated with Mircera (View Usage). Patient had the following side effects: haemoglobin decreased, parkinson's disease (What is parkinson's disease?). Mircera dosage: .

6813632-8 | Renal Failure Chronic
on Jun 29, 2010 Male patient from AUSTRALIA , 64 years of age, was treated with Mircera (View Usage). After Mircera was administered, patient had the following side effects: renal failure chronic. Mircera dosage: .

6803461-3 | Anaemia, Blood Sodium Increased, Hypertensive Encephalopathy, Lung Infection
Patient was taking Mircera (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, blood sodium increased, hypertensive encephalopathy, lung infection on Jun 23, 2010 from FRANCE Additional patient health information: Male patient , 21 years of age, weighting 110.2 lb, was diagnosed with prophylaxis and. Mircera dosage: Frequency: Monthly. During the same period patient was treated with MABTHERA (View Mabthera Review and Mabthera Label ), BACTRIM (View Bactrim Review and Bactrim Label ), VENOFER (View Venofer Review and Venofer Label ). Patient was hospitalized.

6758763-6 | Anaemia, Papilloedema, Visual Impairment
Adverse event was reported on May 31, 2010 by a Female patient taking Mircera (View Usage) (Dosage: Frequency: Monthly, Form: Infusion.) . Location: IRAN (ISLAMIC REPUBLIC OF) , 32 years of age, Patient had the following side effects: anaemia, papilloedema, visual impairment.

6753677-X | Aplasia Pure Red Cell, Encephalitis
on May 31, 2010 Male patient from FRANCE , weighting 145.5 lb, was treated with Mircera (View Usage). After Mircera was administered, patient had the following side effects: aplasia pure red cell, encephalitis (What is encephalitis?). Mircera dosage: . During the same period patient was treated with NEORECORMON (Indication: Anemia Due To Chronic Renal Insufficiency) (View Neorecormon Review and Neorecormon Label ), EPREX (Indication: Anemia Due To Chronic Renal Insufficiency) (View Eprex Review and Eprex Label ), ZOVIRAX (View Zovirax Review and Zovirax Label ), DEPAKENE (View Depakene Review and Depakene Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), MONICOR L.P. (View Monicor L.p. Review and Monicor L.p. Label ), LASIX (View Lasix Review and Lasix Label ), DIFFU K (View Diffu K Review and Diffu K Label ).

6737995-7 | Oesophageal Varices Haemorrhage
on May 18, 2010 Male patient from CHILE , 81 years of age, was treated with Mircera (View Usage). Patient experienced the following unwanted or unexpected effects: oesophageal varices haemorrhage. Mircera dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), PROPRANOLOL (Dose: 1 Tablet) (View Propranolol Review and Propranolol Label ), SPIRONOLACTONE (Dose: 1 Tablet) (View Spironolactone Review and Spironolactone Label ), LACTULOSE (Dose: 1 Tablet) (View Lactulose Review and Lactulose Label ). Patient was hospitalized.

6737963-5 | Dermatitis Bullous
Patient was taking Mircera (View Usage). Patient had the following side effects: dermatitis bullous on May 18, 2010 from FRANCE Additional patient health information: Female patient , 80 years of age, . Mircera dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ATARAX (View Atarax Review and Atarax Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), HOMEOPLASMINE (View Homeoplasmine Review and Homeoplasmine Label ). Patient was hospitalized.

6709592-0 | Aplasia Pure Red Cell, Shock
Adverse event was reported on Apr 30, 2010 by a Female patient taking Mircera (View Usage) (Dosage: ) was diagnosed with haemodialysis and. Location: GREECE , 60 years of age, After Mircera was administered, patient had the following side effects: aplasia pure red cell, shock. During the same period patient was treated with NEORECORMON (View Neorecormon Review and Neorecormon Label ), LEVOCARNITINE (View Levocarnitine Review and Levocarnitine Label ), NEUROBION (View Neurobion Review and Neurobion Label ), CILROTON (View Cilroton Review and Cilroton Label ), FERINJECT (View Ferinject Review and Ferinject Label ).

6702160-6 | Dermatitis Bullous
on Apr 27, 2010 Female patient from FRANCE , 90 years of age, was treated with Mircera (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis bullous. Mircera dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ATARAX (View Atarax Review and Atarax Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), HOMEOPLASMINE (View Homeoplasmine Review and Homeoplasmine Label ). Patient was hospitalized.

6702005-4 | Anaphylactoid Reaction
on Apr 21, 2010 Female patient from FRANCE , 25 years of age, weighting 112.4 lb, was treated with Mircera (View Usage). Patient had the following side effects: anaphylactoid reaction. Mircera dosage: .

6701952-7 | Aplasia Pure Red Cell
Patient was taking Mircera (View Usage). After Mircera was administered, patient had the following side effects: aplasia pure red cell on Apr 26, 2010 from GREECE Additional patient health information: Female patient , 60 years of age, was diagnosed with haemodialysis and. Mircera dosage: . During the same period patient was treated with NEORECORMON (View Neorecormon Review and Neorecormon Label ), LEVOCARNITINE (View Levocarnitine Review and Levocarnitine Label ), NEUROBION (View Neurobion Review and Neurobion Label ), CILROTON (View Cilroton Review and Cilroton Label ), FERINJECT (View Ferinject Review and Ferinject Label ).

6700325-0 | Anaemia, Cardiac Disorder, Condition Aggravated, Haemoglobin Decreased, Peritoneal Dialysis
Adverse event was reported on Apr 22, 2010 by a Female patient taking Mircera (View Usage) (Dosage: Dose Reported: 100 Per Month, Form:pre-filled Syringe, Date Of Last Administration:19 February 2010.) was diagnosed with diabetes mellitus, stent placement, coronary artery disease (What is coronary artery disease?) and. Location: POLAND , weighting 195.3 lb, Patient experienced the following unwanted or unexpected effects: anaemia, cardiac disorder, condition aggravated, haemoglobin decreased, peritoneal dialysis. During the same period patient was treated with NEORECORMON (Dose Reported: 4000 U Per Week Form : Pre-filled Syringe) (View Neorecormon Review and Neorecormon Label ), EPREX (Dose: 4000 U Per Week Form : Pre-filled Syringe) (View Eprex Review and Eprex Label ), GENSULIN R (Dose Reported: 16 U Every Day) (View Gensulin R Review and Gensulin R Label ), AREPLEX (View Areplex Review and Areplex Label ), EFFOX (View Effox Review and Effox Label ), METOCARD (View Metocard Review and Metocard Label ), POLOCARD (View Polocard Review and Polocard Label ). Patient was hospitalized.

6692724-0 | Anaemia, Haematocrit Decreased
on Apr 14, 2010 Female patient from CHILE , 21 years of age, was diagnosed with anaemia and was treated with Mircera (View Usage). Patient had the following side effects: anaemia, haematocrit decreased. Mircera dosage: Frequency: 1 Dose Per Month. During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), EPOETIN (View Epoetin Review and Epoetin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CALCIUM (Start Date Reported: More Than A Year) (View Calcium Review and Calcium Label ), IRON (Start Date Reported: More Than A Year) (View Iron Review and Iron Label ). Patient was hospitalized.

6681265-2 | Aplasia Pure Red Cell
on Apr 11, 2010 Female patient from GREECE , 60 years of age, was treated with Mircera (View Usage). After Mircera was administered, patient had the following side effects: aplasia pure red cell. Mircera dosage: . During the same period patient was treated with NEORECORMON (View Neorecormon Review and Neorecormon Label ).

6660767-9 | Oral Pain, Rash, Tongue Oedema
Patient was taking Mircera (View Usage). Patient experienced the following unwanted or unexpected effects: oral pain, rash (What is rash?), tongue oedema on Mar 25, 2010 from FRANCE Additional patient health information: Male patient , 40 years of age, . Mircera dosage: .

6649425-4 | Haemoglobin Decreased, Haemolytic Anaemia
Adverse event was reported on Mar 16, 2010 by a Female patient taking Mircera (View Usage) (Dosage: Dose Reported: 100 Per Month, Form:pre-filled Syringe, Date Of Last Administration:19 February 2010.) was diagnosed with diabetes mellitus, stent placement, coronary artery disease (What is coronary artery disease?) and. Location: POLAND , weighting 195.3 lb, Patient had the following side effects: haemoglobin decreased, haemolytic anaemia. During the same period patient was treated with NEORECORMON (Dose Reported: 4000 U Per Week Form : Pre-filled Syringe) (View Neorecormon Review and Neorecormon Label ), EPREX (Dose: 4000 U Per Week Form : Pre-filled Syringe) (View Eprex Review and Eprex Label ), GENSULIN R (Dose Reported: 16 U Every Day) (View Gensulin R Review and Gensulin R Label ), AREPLEX (View Areplex Review and Areplex Label ), EFFOX (View Effox Review and Effox Label ), METOCARD (View Metocard Review and Metocard Label ), POLOCARD (View Polocard Review and Polocard Label ). Patient was hospitalized.

6646240-2 | Myocardial Infarction
on Mar 16, 2010 Male patient from MEXICO , 21 years of age, weighting 124.6 lb, was diagnosed with hypertension and was treated with Mircera (View Usage). After Mircera was administered, patient had the following side effects: myocardial infarction. Mircera dosage: Frequency Reported As Single Dose.. During the same period patient was treated with FELODIPINO (View Felodipino Review and Felodipino Label ).

6636386-7 | Myocardial Infarction
on Mar 11, 2010 Male patient from MEXICO , 21 years of age, was treated with Mircera (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction. Mircera dosage: Frequency Reported As Single Dose..

6634462-6 | Grand Mal Convulsion
Patient was taking Mircera (View Usage). Patient had the following side effects: grand mal convulsion on Mar 02, 2010 from MEXICO Additional patient health information: Female patient , weighting 132.3 lb, was diagnosed with hypertension, prophylaxis and. Mircera dosage: . During the same period patient was treated with CANDESARTAN (Dose: 16 Mg) (View Candesartan Review and Candesartan Label ), METOPROLOL (Dose: 50 Mg) (View Metoprolol Review and Metoprolol Label ), OMEPRAZOLE (Dose:20 Mg) (View Omeprazole Review and Omeprazole Label ), SODIUM CARBONATE (Dose: 1 Gm) (View Sodium Carbonate Review and Sodium Carbonate Label ).

6628351-0 | Abdominal Pain, Cerebrovascular Accident, Erythroblast Count Increased, Facial Paresis, Haematocrit Decreased, Headache, Herpes Zoster, Platelet Count Decreased, White Blood Cell Count Increased
Adverse event was reported on Feb 26, 2010 by a Female patient taking Mircera (View Usage) (Dosage: Form: Prefilled Syringes) . Location: GREECE , weighting 113.1 lb, After Mircera was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), cerebrovascular accident, erythroblast count increased, facial paresis, haematocrit decreased, headache (What is headache?), herpes zoster, platelet count decreased, white blood cell count increased. During the same period patient was treated with NEORECORMON (View Neorecormon Review and Neorecormon Label ), TITRALAC (View Titralac Review and Titralac Label ), RENAGEL (View Renagel Review and Renagel Label ), ONE ALPHA (View One-alpha Review and One-alpha Label ), CAPOTEN (View Capoten Review and Capoten Label ), NORVASC (View Norvasc Review and Norvasc Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), DIGOXIN (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

6612262-0 | Haemoglobin Decreased, Haemolytic Anaemia
on Feb 23, 2010 Female patient from POLAND , weighting 195.3 lb, was diagnosed with diabetes mellitus, stent placement, coronary artery disease (What is coronary artery disease?) and was treated with Mircera (View Usage). Patient experienced the following unwanted or unexpected effects: haemoglobin decreased, haemolytic anaemia. Mircera dosage: Dose Reported: 100 Per Month Form : Pre-filled Syringe. During the same period patient was treated with NEORECORMON (Dose Reported: 4000 U Per Week Form : Pre-filled Syringe) (View Neorecormon Review and Neorecormon Label ), EPREX (Dose: 4000 U Per Week Form : Pre-filled Syringe) (View Eprex Review and Eprex Label ), GENSULIN R (Dose Reported: 16 U Every Day) (View Gensulin R Review and Gensulin R Label ), AREPLEX (View Areplex Review and Areplex Label ), EFFOX (View Effox Review and Effox Label ), METOCARD (View Metocard Review and Metocard Label ), POLOCARD (View Polocard Review and Polocard Label ). Patient was hospitalized.

6608234-2 | Aplasia Pure Red Cell, Haemoglobin Decreased
on Feb 19, 2010 Female patient from POLAND , weighting 195.3 lb, was diagnosed with diabetes mellitus, stent placement, coronary artery disease (What is coronary artery disease?) and was treated with Mircera (View Usage). Patient had the following side effects: aplasia pure red cell, haemoglobin decreased. Mircera dosage: Dose Reported: 100 Per Month Form : Pre-filled Syringe. During the same period patient was treated with NEORECORMON (Dose Reported: 4000 U Per Week Form : Pre-filled Syringe) (View Neorecormon Review and Neorecormon Label ), EPREX (Dose: 4000 U Per Week Form : Pre-filled Syringe) (View Eprex Review and Eprex Label ), GENSULIN R (Dose Reported: 16 U Every Day) (View Gensulin R Review and Gensulin R Label ), AREPLEX (View Areplex Review and Areplex Label ), EFFOX (View Effox Review and Effox Label ), METOCARD (View Metocard Review and Metocard Label ), POLOCARD (View Polocard Review and Polocard Label ). Patient was hospitalized.

6604653-9 | Erythroblast Count Increased, Facial Paresis, Headache, Herpes Zoster, Platelet Count Decreased, White Blood Cell Count Increased
Patient was taking Mircera (View Usage). After Mircera was administered, patient had the following side effects: erythroblast count increased, facial paresis, headache (What is headache?), herpes zoster, platelet count decreased, white blood cell count increased on Feb 24, 2010 from GREECE Additional patient health information: Female patient , 35 years of age, . Mircera dosage: . Patient was hospitalized.

6596201-7 | Cardiac Failure Congestive, Haemoglobin Decreased
Adverse event was reported on Feb 17, 2010 by a Male patient taking Mircera (View Usage) (Dosage: ) . Location: HONG KONG , weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, haemoglobin decreased. During the same period patient was treated with SEVELAMER HYDROCHLORIDE (View Sevelamer Hydrochloride Review and Sevelamer Hydrochloride Label ), ROCALTROL (Frequency Reported As Every Night) (View Rocaltrol Review and Rocaltrol Label ), LIPITOR (View Lipitor Review and Lipitor Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ). Patient was hospitalized.

6590907-1 | Erythroblast Count Increased, Facial Paresis, Headache, Herpes Zoster, Platelet Count Decreased, White Blood Cell Count Increased
on Feb 09, 2010 Female patient from GREECE , 35 years of age, was treated with Mircera (View Usage). Patient had the following side effects: erythroblast count increased, facial paresis, headache (What is headache?), herpes zoster, platelet count decreased, white blood cell count increased. Mircera dosage: . Patient was hospitalized.

6583725-1 | Cardiac Failure Congestive, Haemoglobin Decreased
on Feb 05, 2010 Male patient from HONG KONG , weighting 165.3 lb, was treated with Mircera (View Usage). After Mircera was administered, patient had the following side effects: cardiac failure congestive, haemoglobin decreased. Mircera dosage: . During the same period patient was treated with SEVELAMER HYDROCHLORIDE (View Sevelamer Hydrochloride Review and Sevelamer Hydrochloride Label ), ROCALTROL (Frequency Reported As Every Night) (View Rocaltrol Review and Rocaltrol Label ), LIPITOR (View Lipitor Review and Lipitor Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ). Patient was hospitalized.

6565289-1 | Haematemesis
Patient was taking Mircera (View Usage). Patient experienced the following unwanted or unexpected effects: haematemesis on Jan 25, 2010 from FRANCE Additional patient health information: Female patient , weighting 97.00 lb, . Mircera dosage: Last Dose Prior To Sae: 13 March 2009. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), AMLOR (View Amlor Review and Amlor Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6542980-4 | Cardiac Failure, Platelet Count Decreased, Syncope, Venous Thrombosis
Adverse event was reported on Jan 11, 2010 by a Female patient taking Mircera (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?), thrombophlebitis and. Location: BULGARIA , weighting 132.3 lb, Patient had the following side effects: cardiac failure, platelet count decreased, syncope, venous thrombosis. During the same period patient was treated with FURANTIL (Dose: 1 Tablet, Frequency: Every 2-nd Day) (View Furantil Review and Furantil Label ), ALBUMIN (HUMAN) (Frequency: 4 X Monthly) (View Albumin (human) Review and Albumin (human) Label ), CEFTRIAXONE (Frequency: 2 X Daily) (View Ceftriaxone Review and Ceftriaxone Label ), CLEXANE (Frequency: 1 X Daily) (View Clexane Review and Clexane Label ), ATENOLOL (Frequency: 1 X Daily) (View Atenolol Review and Atenolol Label ).

6503031-0 | Haemoglobin Decreased
on Dec 10, 2009 Female patient from SOUTH AFRICA , weighting 103.6 lb, was treated with Mircera (View Usage). After Mircera was administered, patient had the following side effects: haemoglobin decreased. Mircera dosage: Last Date Of Administration Before The Anti Erythropoeitin And Anti Cera Antibodytest On 09 Oct 2009.

6457192-2 | Haemoglobin Decreased
on Nov 13, 2009 Female patient from SOUTH AFRICA , weighting 103.6 lb, was treated with Mircera (View Usage). Patient experienced the following unwanted or unexpected effects: haemoglobin decreased. Mircera dosage: Last Date Of Administration Before The Anti Erythropoeitin And Anti Cera Antibodytest On 09 Oct 2009.

6441009-6 | Hypertension, Transient Ischaemic Attack
Patient was taking Mircera (View Usage). Patient had the following side effects: hypertension, transient ischaemic attack on Nov 02, 2009 from RUSSIAN FEDERATION Additional patient health information: Male patient , 39 years of age, . Mircera dosage: . During the same period patient was treated with HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SACCHARUM (View Saccharum Review and Saccharum Label ).

6441008-4 | Haemoptysis, Pulmonary Embolism
Adverse event was reported on Nov 02, 2009 by a Male patient taking Mircera (View Usage) (Dosage: ) . Location: RUSSIAN FEDERATION , 60 years of age, After Mircera was administered, patient had the following side effects: haemoptysis, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with MONOPRIL (View Monopril Review and Monopril Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CURANTYL (View Curantyl Review and Curantyl Label ).

6440962-4 | Orchitis
on Nov 02, 2009 Male patient from RUSSIAN FEDERATION , 27 years of age, was treated with Mircera (View Usage). Patient experienced the following unwanted or unexpected effects: orchitis. Mircera dosage: .

6437246-7 | Eczema, Nail Injury, Oedema Peripheral
on Nov 06, 2009 Female patient from FRANCE , weighting 163.1 lb, was treated with Mircera (View Usage). Patient had the following side effects: eczema (What is eczema?), nail injury, oedema peripheral. Mircera dosage: Received 2 Injections. During the same period patient was treated with TEMERIT (View Temerit Review and Temerit Label ), ATACAND (View Atacand Review and Atacand Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), VASTAREL (View Vastarel Review and Vastarel Label ), ZOCOR (View Zocor Review and Zocor Label ).

6420993-0 | Headache, Hypertension, Leukocytosis, Thrombocytosis
Patient was taking Mircera (View Usage). After Mircera was administered, patient had the following side effects: headache (What is headache?), hypertension, leukocytosis, thrombocytosis on Oct 19, 2009 from FRANCE Additional patient health information: Male patient , 81 years of age, . Mircera dosage: Frequency; Once. During the same period patient was treated with NEORECORMON (Indication; Wegner's Disease) (View Neorecormon Review and Neorecormon Label ), ENDOXAN (View Endoxan Review and Endoxan Label ).

6415620-2 | Renal Failure
Adverse event was reported on Oct 16, 2009 by a Male patient taking Mircera (View Usage) (Dosage: Frequency: Single Dose) . Location: ECUADOR , 50 years of age, Patient experienced the following unwanted or unexpected effects: renal failure.

6410338-4 | Burning Sensation, Erythema, Stomatitis
on Oct 12, 2009 Female patient from FRANCE , 63 years of age, was treated with Mircera (View Usage). Patient had the following side effects: burning sensation, erythema, stomatitis. Mircera dosage: .

6406881-4 | Diabetes Mellitus
on Oct 13, 2009 Male patient from CHILE , 67 years of age, was diagnosed with anaemia and was treated with Mircera (View Usage). After Mircera was administered, patient had the following side effects: diabetes mellitus. Mircera dosage: .

6405311-6 | Renal Failure Chronic
Patient was taking Mircera (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure chronic on Oct 14, 2009 from CHILE Additional patient health information: Male patient , 75 years of age, was diagnosed with anaemia and. Mircera dosage: .

6401743-0 | Renal Failure
Adverse event was reported on Oct 06, 2009 by a Male patient taking Mircera (View Usage) (Dosage: Frequency: Single Dose) . Location: ECUADOR , 50 years of age, Patient had the following side effects: renal failure.

6396454-4 | Eosinophilia
on Sep 28, 2009 Male patient from INDIA , 72 years of age, weighting 99.21 lb, was treated with Mircera (View Usage). After Mircera was administered, patient had the following side effects: eosinophilia. Mircera dosage: . During the same period patient was treated with IRBESARTAN (View Irbesartan Review and Irbesartan Label ).

6396453-2 | Blood Parathyroid Hormone Increased, Cerebrovascular Accident, Multi-organ Disorder, Pneumonia, Pulmonary Oedema, Troponin Increased
on Sep 30, 2009 Female patient from IRELAND , weighting 154.3 lb, was treated with Mircera (View Usage). Patient experienced the following unwanted or unexpected effects: blood parathyroid hormone increased, cerebrovascular accident, multi-organ disorder, pneumonia (What is pneumonia?), pulmonary oedema, troponin increased. Mircera dosage: Dosage Regimen Reported As Q2/52.. During the same period patient was treated with BUMETANIDE (View Bumetanide Review and Bumetanide Label ), AMODIPIN (View Amodipin Review and Amodipin Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), NEXIUM (View Nexium Review and Nexium Label ), LOSARTAN POSTASSIUM (View Losartan Postassium Review and Losartan Postassium Label ), HYDROCORTISON (View Hydrocortison Review and Hydrocortison Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ).

6383522-6 | Arthralgia, Myalgia
Patient was taking Mircera (View Usage). Patient had the following side effects: arthralgia, myalgia on Sep 21, 2009 from FRANCE Additional patient health information: Male patient , weighting 187.4 lb, was diagnosed with hypertension, platelet aggregation inhibition, anaemia and. Mircera dosage: One Only Administration Dose: 120 Ug. During the same period patient was treated with INEGY (Dose: In The Evening) (View Inegy Review and Inegy Label ), STAGID (Dose: 3 Unit Per 24 Hours) (View Stagid Review and Stagid Label ), APROVEL (Reported As Aprovel 150 Dose: 1 Unit) (View Aprovel Review and Aprovel Label ), ASASANTINE (Reported As Asasantine Lp 200/25 Dose: 1 Unit Twice) (View Asasantine Review and Asasantine Label ), UN ALFA (Dose: 1 Tablet Per Day) (View Un Alfa Review and Un Alfa Label ), TARDYFERON (Dose: In The Morning) (View Tardyferon Review and Tardyferon Label ).